Elevance Health IncElevance raised its 2026 earnings guidance and trades at a low forward P/S ratio of 0.46.
Zacks Investment Research identifies Elevance Health, Tenet Healthcare, and Aveanna Healthcare Holdings as attractively valued medical stocks amid renewed US-Iran military confrontation and geopolitical uncertainty. The firm notes that healthcare demand remains non-discretionary, and these companies carry a Zacks Rank #2 (Buy) with Value and Growth scores of A. Elevance Health raised its 2026 earnings guidance and trades at a forward price-to-sales ratio of 0.46, below its industry average. Tenet Healthcare reaffirmed its 2026 outlook with ambulatory operations generating nearly half of EBITDA, while Aveanna Healthcare raised full-year guidance after first-quarter revenue climbed nearly 16% and adjusted EBITDA rose more than 25%. All three have outperformed the Zacks Medical sector year-to-date, with Elevance and Aveanna also beating the S&P 500.
Elevance Health IncElevance raised its 2026 earnings guidance and trades at a low forward P/S ratio of 0.46.
Tenet Healthcare CorporationTenet reaffirmed its 2026 outlook with ambulatory operations generating nearly half of EBITDA.
Aveanna Healthcare Holdings IncAveanna raised full-year guidance after Q1 revenue rose ~16% and adjusted EBITDA rose >25%.